Anthony Petrone
Stock Analyst at Mizuho Securities
(4.48)
# 1,155
Out of 4,604 analysts
654
Total ratings
53.1%
Success rate
8.1%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DXCM DexCom | Maintained: Buy | $95 | $82.66 | +14.93% | 14 | Aug 4, 2026 | |
| INSP Inspire Medical Systems | Maintained: Buy | $55 → $65 | $60.09 | +8.17% | 20 | Aug 4, 2026 | |
| BSX Boston Scientific | Maintained: Buy | $70 → $60 | $47.74 | +25.68% | 25 | Jul 31, 2026 | |
| AXGN Axogen | Maintained: Buy | $55 → $58 | $45.22 | +28.26% | 4 | Jul 31, 2026 | |
| GKOS Glaukos | Maintained: Buy | $160 → $185 | $170.93 | +8.23% | 27 | Jul 31, 2026 | |
| GEHC GE HealthCare Technologies | Maintained: Buy | $80 → $85 | $70.24 | +21.01% | 21 | Jul 31, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $120 → $115 | $101.50 | +13.30% | 37 | Jul 29, 2026 | |
| NPCE NeuroPace | Maintained: Buy | $22 | $13.70 | +60.58% | 2 | Jul 28, 2026 | |
| FOCL EDAP TMS | Initiated Coverage: Buy | $15 | $6.09 | +146.31% | 1 | Jul 17, 2026 | |
| EW Edwards Lifesciences | Maintained: Buy | $100 → $105 | $88.97 | +18.02% | 30 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $90 | $83.60 | +7.66% | 70 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $525 → $400 | $375.20 | +6.61% | 18 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $235 → $220 | $224.03 | -1.80% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $140 → $145 | $136.78 | +6.01% | 23 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $20 | $19.59 | +2.09% | 8 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $9.26 | +83.59% | 34 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $95 | $78.15 | +21.57% | 28 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $18 | $5.18 | +247.49% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $105 | $91.25 | +15.07% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 69.28 → CHF 65.20 | CHF 56.74 | +14.91% | 24 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $85 | $74.84 | +13.58% | 39 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $120 → $100 | $85.99 | +16.29% | 28 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 | $18.56 | +13.15% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $27 | $22.86 | +18.11% | 31 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $7 | $4.10 | +70.73% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $5 | $3.57 | +40.06% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $4.16 | +92.31% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $125 → $115 | $105.71 | +8.79% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $37.90 | -20.84% | 5 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $46.70 | +114.13% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $163.18 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175 | $98.16 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $79.00 | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $0.915 | n/a | 3 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 | $61.29 | n/a | 7 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $17.65 | n/a | 1 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.3847 | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $18 | $12.39 | n/a | 8 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.000001 | n/a | 5 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.2743 | n/a | 7 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | - | n/a | 4 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $235.09 | n/a | 1 | Aug 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $97 | $13.27 | n/a | 1 | Aug 2, 2016 |
DexCom
Aug 4, 2026
Maintained: Buy
Price Target: $95
Current: $82.66
Upside: +14.93%
Inspire Medical Systems
Aug 4, 2026
Maintained: Buy
Price Target: $55 → $65
Current: $60.09
Upside: +8.17%
Boston Scientific
Jul 31, 2026
Maintained: Buy
Price Target: $70 → $60
Current: $47.74
Upside: +25.68%
Axogen
Jul 31, 2026
Maintained: Buy
Price Target: $55 → $58
Current: $45.22
Upside: +28.26%
Glaukos
Jul 31, 2026
Maintained: Buy
Price Target: $160 → $185
Current: $170.93
Upside: +8.23%
GE HealthCare Technologies
Jul 31, 2026
Maintained: Buy
Price Target: $80 → $85
Current: $70.24
Upside: +21.01%
Lantheus Holdings
Jul 29, 2026
Maintained: Buy
Price Target: $120 → $115
Current: $101.50
Upside: +13.30%
NeuroPace
Jul 28, 2026
Maintained: Buy
Price Target: $22
Current: $13.70
Upside: +60.58%
EDAP TMS
Jul 17, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $6.09
Upside: +146.31%
Edwards Lifesciences
Jul 15, 2026
Maintained: Buy
Price Target: $100 → $105
Current: $88.97
Upside: +18.02%
Jul 15, 2026
Maintained: Buy
Price Target: $85 → $90
Current: $83.60
Upside: +7.66%
Jul 15, 2026
Maintained: Hold
Price Target: $525 → $400
Current: $375.20
Upside: +6.61%
Jul 15, 2026
Maintained: Buy
Price Target: $235 → $220
Current: $224.03
Upside: -1.80%
Jul 15, 2026
Maintained: Hold
Price Target: $140 → $145
Current: $136.78
Upside: +6.01%
Jul 15, 2026
Maintained: Hold
Price Target: $24 → $20
Current: $19.59
Upside: +2.09%
Jul 15, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $9.26
Upside: +83.59%
Jul 15, 2026
Maintained: Buy
Price Target: $90 → $95
Current: $78.15
Upside: +21.57%
Jul 15, 2026
Maintained: Buy
Price Target: $20 → $18
Current: $5.18
Upside: +247.49%
Jul 15, 2026
Maintained: Buy
Price Target: $100 → $105
Current: $91.25
Upside: +15.07%
Jul 15, 2026
Maintained: Buy
Price Target: CHF 69.28 → CHF 65.20
Current: CHF 56.74
Upside: +14.91%
Jun 3, 2026
Maintained: Buy
Price Target: $100 → $85
Current: $74.84
Upside: +13.58%
Jun 3, 2026
Maintained: Buy
Price Target: $120 → $100
Current: $85.99
Upside: +16.29%
Jun 3, 2026
Maintained: Buy
Price Target: $21
Current: $18.56
Upside: +13.15%
May 14, 2026
Maintained: Hold
Price Target: $22 → $27
Current: $22.86
Upside: +18.11%
May 7, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $4.10
Upside: +70.73%
May 6, 2026
Maintained: Hold
Price Target: $12 → $5
Current: $3.57
Upside: +40.06%
Apr 30, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $4.16
Upside: +92.31%
Apr 20, 2026
Maintained: Hold
Price Target: $125 → $115
Current: $105.71
Upside: +8.79%
Apr 13, 2026
Maintained: Buy
Price Target: $30
Current: $37.90
Upside: -20.84%
Apr 13, 2026
Maintained: Buy
Price Target: $100
Current: $46.70
Upside: +114.13%
Jun 13, 2025
Maintained: Buy
Price Target: $65
Current: $163.18
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $175
Current: $98.16
Upside: n/a
Sep 16, 2021
Rated: Buy
Price Target: $70
Current: $79.00
Upside: n/a
Aug 11, 2021
Rated: Buy
Price Target: $20
Current: $0.915
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $45
Current: $61.29
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $86
Current: $17.65
Upside: n/a
Sep 17, 2020
Initiated Coverage: Buy
Price Target: $15
Current: $0.3847
Upside: n/a
Aug 13, 2020
Maintained: Hold
Price Target: $25 → $18
Current: $12.39
Upside: n/a
Dec 3, 2019
Maintained: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Aug 17, 2018
Reiterated: Buy
Price Target: $7 → $6
Current: $0.2743
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: $80 → $95
Current: -
Upside: n/a
Aug 25, 2017
Maintained: Buy
Price Target: $93
Current: $235.09
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $97
Current: $13.27
Upside: n/a